Acclarent Release: First Patients Treated With Only Surgical Intervention For Persistent Eustachian Tube Dysfunction In The U.S
Healthcare Providers using New Device Available for Interviews
WHAT: The first balloon catheter device available in the U.S. for use by ear, nose and throat (ENT) surgeons to dilate the Eustachian tube to treat persistent Eustachian tube dysfunction (ETD).1
Since its introduction, physicians across the country have performed more than 160 surgeries using the ACCLARENT AERA™ Eustachian Tube Balloon Dilation System, developed by Acclarent, Inc., part of Johnson & Johnson Medical Devices Companies.2 The device provides a minimally-invasive option for ENTs to treat the source of ETD by dilating the Eustachian tube in adult patients.
WHY: ETD is a condition often marked by ear pain, pressure and dulled hearing.3 Currently, it is treated with medications or ear tube surgery, one of the most commonly performed surgeries in the U.S.4 These options relieve symptoms, but do not correct the underlying condition, which can lead some patients to develop chronic symptoms, persistent complaints or more serious conditions such as middle ear effusion, infections and related long-term complications.
The ACCLARENT AERA™ leverages Acclarent balloon catheter technology to dilate dysfunctional Eustachian tubes by inserting a small balloon into the tube and inflating the balloon. It also offers the necessary flexibility to adapt to Eustachian tube anatomy to help surgeons minimize trauma through precise access and positioning.
WHO:
• Dr. Dennis Poe, Otologist and Neurotologist, Professor in the Department of Otolaryngology at Harvard Medical School.
• Dr. Michael Seidman, Director of Otologic/Neurotologic Surgery and Medical Director of Wellness for Henry Ford Health System, Professor of OTO-HNS for University of Central Florida, and American Academy of Otolaryngology-Head and Neck Surgery Board of Directors member.
• Dr. Marc Dean, Otolaryngologist practicing in Fort Worth, Texas; serves as Assistant Professor in Otolaryngology/HNS at Louisiana State University.
• Dr. Bill Brown, Otolaryngologist practicing with South Florida ENT Associates.
FAST FACTS ABOUT ETD:
• ETD affects approximately 1 percent of adults worldwide.5
• A normal Eustachian tube helps regulate pressure in the ear, but when the tube is not functioning properly, patients may feel a sense of fullness or clogging in their ear.
• People with ETD can experience earaches, pressure, infections, hearing loss or ringing in the ear.6
• Other possible symptoms may include the following symptoms: muffled hearing, fullness of the ear, and dizziness.6
CONTACT: Please contact Emma Reynolds at ereynol4@ITS.JNJ.com or 949-453-6465 with any questions or to schedule an interview.
MORE INFORMATION: For more information about the ACCLARENT AERA™ Eustachian Tube Balloon Dilation System, please visit www.acclarent.com.
WHAT: The first balloon catheter device available in the U.S. for use by ear, nose and throat (ENT) surgeons to dilate the Eustachian tube to treat persistent Eustachian tube dysfunction (ETD).1
Since its introduction, physicians across the country have performed more than 160 surgeries using the ACCLARENT AERA™ Eustachian Tube Balloon Dilation System, developed by Acclarent, Inc., part of Johnson & Johnson Medical Devices Companies.2 The device provides a minimally-invasive option for ENTs to treat the source of ETD by dilating the Eustachian tube in adult patients.
WHY: ETD is a condition often marked by ear pain, pressure and dulled hearing.3 Currently, it is treated with medications or ear tube surgery, one of the most commonly performed surgeries in the U.S.4 These options relieve symptoms, but do not correct the underlying condition, which can lead some patients to develop chronic symptoms, persistent complaints or more serious conditions such as middle ear effusion, infections and related long-term complications.
The ACCLARENT AERA™ leverages Acclarent balloon catheter technology to dilate dysfunctional Eustachian tubes by inserting a small balloon into the tube and inflating the balloon. It also offers the necessary flexibility to adapt to Eustachian tube anatomy to help surgeons minimize trauma through precise access and positioning.
WHO:
• Dr. Dennis Poe, Otologist and Neurotologist, Professor in the Department of Otolaryngology at Harvard Medical School.
• Dr. Michael Seidman, Director of Otologic/Neurotologic Surgery and Medical Director of Wellness for Henry Ford Health System, Professor of OTO-HNS for University of Central Florida, and American Academy of Otolaryngology-Head and Neck Surgery Board of Directors member.
• Dr. Marc Dean, Otolaryngologist practicing in Fort Worth, Texas; serves as Assistant Professor in Otolaryngology/HNS at Louisiana State University.
• Dr. Bill Brown, Otolaryngologist practicing with South Florida ENT Associates.
FAST FACTS ABOUT ETD:
• ETD affects approximately 1 percent of adults worldwide.5
• A normal Eustachian tube helps regulate pressure in the ear, but when the tube is not functioning properly, patients may feel a sense of fullness or clogging in their ear.
• People with ETD can experience earaches, pressure, infections, hearing loss or ringing in the ear.6
• Other possible symptoms may include the following symptoms: muffled hearing, fullness of the ear, and dizziness.6
CONTACT: Please contact Emma Reynolds at ereynol4@ITS.JNJ.com or 949-453-6465 with any questions or to schedule an interview.
MORE INFORMATION: For more information about the ACCLARENT AERA™ Eustachian Tube Balloon Dilation System, please visit www.acclarent.com.